The app makes those quieter wins visible, which is how a tracker becomes useful beyond the first burst of motivation and keeps helping when the novelty of weight loss has worn off
Individual results vary, results are not guaranteed
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
Blood 108(11):2586, 2006
Unfortunately, surgery is not always possible due to the size and location of the tumor, thus, a better understanding of MPNST initiation and development is required to design novel therapeutics